Skip to main navigation Skip to search Skip to main content

Protocol 161503: Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric Subjects with Primary Immunodeficiency Diseases

Project: Research

Project Details

StatusFinished
Effective start/end date04/1/18 → 04/1/21

Funding

  • Baxalta US Incorporated: $15,000.00